- 
                        IntroducedFeb 26, 2025
- 
                        Passed House
- 
                        Passed Senate
- 
                        Signed into Law
                    
                    
                    AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT (Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name listed with the department of business regulation.)
                
                
            
        Last Action See all actions
                         House • Mar 06, 2025: 03/06/2025 Committee recommended measure be held for further study
Latest Bill Text See all bill texts
                        
                        
                        
            Summary/Bill Text
Comments on HB 5632
Tweets
Whip Lists
Sponsors
                Votes
                        
  
       Actions
            - Mar 06, 2025 | House- 03/06/2025 Committee recommended measure be held for further study
 
- Feb 28, 2025 | House- 02/28/2025 Scheduled for hearing and/or consideration (03/06/2025)
 
- Feb 26, 2025 | House- 02/26/2025 Introduced, referred to House Health & Human Services
 
Bill Texts 
        
            
    



 Report a comment
 Report a comment